Refractory Small Lymphocytic Lymphoma

DBCOND0029146Hematologic Neoplasms

Refractory Small Lymphocytic Lymphoma is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Classified under
Indicated drugs

What you can answer from here — as of October 18, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
41Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Refractory Small Lymphocytic Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In